PubMed Malhotra, A., Grunstein, R.R., Fietze, I., Weaver, T.E., Redline, S., Azarbarzin, A., Sands, S.A., Schwab, R.J., Dunn, J.P., Chakladar, S., Bunck, M.C., Bednarik, J., Hauber, A., Rosenberg, R., & SURMOUNT-OSA Investigators
Who Is a Candidate for Zepbound? Candidates for Zepbound are typically those who: Have a BMI of 30 or higher Have a BMI of 27 or higher with at least one weight-related health condition such as hypertension, type 2 diabetes, or high cholesterol Have struggled with weight loss through diet and exercise alone Are committed to making lifestyle changes in conjunction with their medication A consultation with Dr
Dietary supplementation with a novel l-carnitine multi-micronutrient in idiopathic male subfertility involving oligo-, astheno-, teratozoospermia: A randomized clinical study
The monthly dosing interval may inherently reduce GI side effects by avoiding the peak-trough fluctuations associated with more frequent dosing
For instance, GLP-1 receptor agonists often start at a low dose and gradually increase to minimize side effects
At Aptiva Health, the evaluation typically includes: A focused history
